The historical rank and industry rank for Tien Liang BioTech Co's Net Margin % or its related term are showing as below:
ROCO:4127'
s Net Margin % Range Over the Past 10 Years
Min: -39.48 Med: -4.53 Max: 11.25
Current: -2
ROCO:4127's Net Margin % is ranked worse than 68.94% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs ROCO:4127: -2.00
Tien Liang BioTech Co (ROCO:4127) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Tien Liang BioTech Co Net Margin % Related Terms
Tien Liang BioTech Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Tien Liang BioTech Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tien Liang BioTech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tien Liang BioTech Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tien Liang BioTech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Tien Liang BioTech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tien Liang BioTech Co (ROCO:4127) has a Net Margin % of -2.02% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Tien Liang BioTech Co and its competitors. According to the industry distribution chart, Tien Liang BioTech Co ranks #657 out of 953 companies in the Drug Manufacturers industry, placing it in the top 68.9%.
Is Tien Liang BioTech Co's Net Margin % too high?
Tien Liang BioTech Co's current Net Margin % is -2.02%. Based on the distribution chart, Tien Liang BioTech Co ranks #657 out of 953 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tien Liang BioTech Co has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tien Liang BioTech Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Tien Liang BioTech Co ranks #657 out of 953 companies for Net Margin %. This places Tien Liang BioTech Co in the lower half of its industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tien Liang BioTech Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tien Liang BioTech Co's current Net Margin % is -2.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tien Liang BioTech Co stock overvalued right now?
Based on GuruFocus' analysis, Tien Liang BioTech Co (ROCO:4127) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.20, compared to a current price of NT$64.50 — trading 64.5% above its estimated fair value. The current Net Margin % is -2.02%. Tien Liang BioTech Co's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tien Liang BioTech Co (ROCO:4127), the current Net Margin % is -2.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tien Liang BioTech Co (ROCO:4127) Overvalued in 2026?
Based on GuruFocus' analysis, Tien Liang BioTech Co stock appears to be overvalued.
The current stock price of NT$64.50 is trading 64.5% above its estimated GF Value™ of NT$39.20.
GuruFocus considers Tien Liang BioTech Co to be Significantly Overvalued.
Key valuation signals for ROCO:4127:
Net Margin %: -2.02%
GF Value™: NT$39.20 vs. price of NT$64.50 (64.5% above fair value)
No single metric tells the full story. See the ROCO:4127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical, and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis, and hepatic diseases.
38GF Score
Get the complete analysis for ROCO:4127
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4127 has been successfully added to your 
